Skip to main content

Table 3 Sensitivity analysis of Testosterone and DHEA

From: The effects of statins on hyperandrogenism in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials

Excluded study Testosterone DHEA
SMD 95CI SMD 95CI
None −0.47 [−0.76,-0.18] − 0.51 [− 0.97,-0.05]
Seyam 2018 − 0.48 [− 0.84,-0.13] −0.33 [− 0.73,0.06]
Seyam 2017 −0.53 [− 0.85, 0.21] −0.46 [−1.04, 0.13]
Puurunen 2013 −0.53 [−0.83, 0.22] − 0.57 [−1.07,-0.06]
Banaszewska 2011 −0.53 [− 0.85, 0.21] −0.61 [−1.10,-0.12]
Raja 2011 −0.51 [−0.81, 0.20] − 0.43 [− 0.92,0.06]
Rashidi 2011 − 0.44 [− 0.76, 0.12]
Kazerooni 2010 − 0.41 [− 0.72, 0.11] −0.59 [− 1.09,-0.09]
Sathyapalan 2009 −0.39 [− 0.66, 0.12]
Duleba 2005 −0.40 [− 0.70, 0.11] − 0.60 [− 1.05,-0.16]